Company intelligence / Profile preview

GroundTruth

South San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

GroundTruth Bio is a biotechnology company focused on revolutionizing drug discovery by leveraging high-fidelity biological data and advanced machine learning. The company's platform integrates large-scale functional genomics with proprietary computational models to identify novel therapeutic targets and optimize drug candidates. By focusing on "ground truth" biological insights, the company aims to overcome the limitations of traditional screening methods and improve the success rates of clinical development. GroundTruth Bio primarily targets complex diseases in oncology and immunology, developing a pipeline of precision medicines designed to modulate the human immune system.

Therapeutic areas: OncologyImmunology
Modalities: Small moleculeAntibodyCell therapy
Industry: Biotech

Beyond the preview

Go deeper on GroundTruth.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GroundTruth.

Explore the full profile